Sydney M Crago is a journalist who specializes in optometry and ophthalmology. She writes for Optometry Times and Ophthalmology Times, covering topics such as clinical studies, research findings, and advancements in eye health. With a focus on providing accurate and informative content, Sydney aims to keep eyecare professionals and readers updated on the latest developments in the field.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Sydney M Crago’s articles predominantly cover medical research, with a focus on eye health and pharmaceutical industry developments. The coverage includes presentations of scientific data, expert commentary, and announcements related to these topics.
If you are looking to pitch to Sydney M Crago, consider offering expert commentary or insights into recent medical research developments in the field of ophthalmology and pharmaceuticals. Additionally, if you have access to new scientific data or can provide analysis based on such information, it may be particularly appealing for her audience.
Given the specific nature of the topics covered by Sydney M Crago, content related to deep learning in medical research or updates from prestigious associations like ASRS (American Society of Retina Specialists) could also be well-received.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Sydney M Crago
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
By: Sydney M Crago
Nathan Steinle, MD, spoke about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Eleonora Lad, MD, PhD, spoke about her presentation, "Multiwavelength photobiomodulation significantly reduces risk for vision loss and onset of geographic atrophy in dry age-related macular degeneration" at this year's American Society of Retina Specialists (ASRS) meeting in Stockholm, Sweden.
By: Sydney M Crago
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.
Nikoloz Labauri, MD, FVRS, founder of DAVINCI Eye Clinic in Tbilisi, Georgia, discusses his presentation, "Suspensory Macular Buckling for Myopic Traction Maculopathy" at this year's American Society of Retina Specialists (ASRS) meeting in Stockholm, Sweden
Yasha Modi, MD, spoke about the DAVIO phase 2 trial and the upcoming LUGANO phase 3 trial at the annual ASRS meeting in Stockholm, Sweden.
By: Sydney M Crago
Sruthi Arepalli, MD, spoke about her presentation, "Assessing retinal vascular changes in Alzheimer's disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
By: Sydney M Crago
Chase Ludwig, MD, speaks about the effect of vitrectomy on the progression of age-related macular degeneration
By: Sydney M Crago
Consultant ophthalmologist Christiana Dinah, BSc, MB BS, MRes, presented research findings on retinal vein occlusion in the United Kingdom
InMed Pharmaceuticals has been issued 3 US patents, one of which is for an ocular drug delivery formulation for potential use in age-related macular degeneration (AMD). This formulation and use patent has been granted/allowed in the US, Europe, Australia, Japan, and India and is also pending in other jurisdictions.
(833) 317-6278 
